Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Downgrades Bausch Health Companies to Neutral

JP Morgan Downgrades Bausch Health Companies to Neutral

JP Morgan analyst Chris Schott downgrades Bausch Health Companies (NYSE:BHC) from Overweight to Neutral.

byBenzinga Newsdesk

July 29, 2022

1 minute read

JP Morgan analyst Chris Schott downgrades Bausch Health Companies (NYSE:BHC) from Overweight to Neutral.

What’s Going On With Alibaba Stock Thursday?

By Anusuya Lahiri

June 20, 9:34 AM

Alibaba stock lost over 15% in the last 12 months as it battled intense domestic competition and a weak domestic economy.

AIQ

Analyst Ratings

The Latest Analyst Ratings for Apellis Pharmaceuticals

By Benzinga Insights

June 13, 8:04 AM

Within the last quarter, Apellis Pharmaceuticals (NASDAQ:APLS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

APLS

Select Medical Holdings Q2 EPS $0.43 Misses $0.55 Estimate, Sales $1.58B Beat $1.58B Estimate

By Michael Horton

August 4, 6:40 PM

Select Medical Holdings (NYSE:SEM) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.55 by 21.82 percent. This is a 64.75 percent decrease over earnings of $1.22 per share

SEM